首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1461322

下一代定序市場，按產品類型、按定序類型、按應用、按最終用戶、按地理位置

Next Generation Sequencing Market, By Product Type, By Sequencing Type, By Application, By End User, By Geography

出版日期: 2024年03月15日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年下一代定序市場價值為165.1億美元，預計到2031年將達到426.1億美元，2024年至2031年年複合成長率（CAGR）為14.5%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	165.1 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	14.50%	2030/2031 價值預測：	426.1 億美元

次世代定序市佔率 (%)，依地區，2024 年

下一代定序（NGS）是指與第一代桑格定序相比，大幅降低了DNA定序成本、提高了DNA定序速度和通量的高通量DNA定序技術。 NGS 允許研究人員對整個基因組進行定序，並大規模分析基因活性或表現的模式。自 2005 年被發現以來，NGS 平台已經取得了巨大的進步，能夠在一次運行中對數千到數百萬個 DNA 片段進行測序。這種大規模平行定序允許基因組研究中的全面表徵和發現，徹底改變了生物學和生物醫學研究。 NGS 廣泛應用於遺傳學、腫瘤學、藥物基因組學和個人化醫療等各個領域。

市場動態：

全球下一代定序市場的成長是由基因組學和精準醫學在各種疾病中的不斷成長的應用所推動的。癌症盛行率的上升以及對藥物基因組學的日益關注正在推動臨床診斷和監測中對 NGS 平台的需求。基因組學研究活動的不斷成長，加上測序成本的持續下降以及攜帶式和方便用戶使用型測序儀器的推出也推動了市場的成長。然而，由於NGS產生的大量資料和有限的生物資訊學知識促使的資料管理和分析問題仍然是一個課題。同時，單細胞應用程式和基於雲端的 NGS資料管理解決方案的發展帶來了利潤豐厚的成長機會。

研究的主要特點：

該報告對全球下一代定序市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球下一代定序市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球下一代定序市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球下一代定序市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 10 章：競爭格局

Thermo Fisher Scientific Inc.
Agilent Technologies, Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
QIAGEN
Illumina, Inc.
Oxford Nanopore Technologies plc.
BGI
PerkinElmer Genomics
Bio-Rad Laboratories Inc.
Pacific Biosciences
10x Genomics
Promega Corporation
Macrogen Inc.
Eurofins Scientific
DNASTAR Inc.
CD Genomics

第 11 章：分析師觀點

命運之輪
分析師觀點
連貫的機會圖

第 12 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI158

The next generation sequencing market is estimated to be valued at USD 16.51 Bn in 2024 and is expected to reach USD 42.61 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 16.51 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	14.50%	2030/2031 Value Projection:	US$ 42.61 Bn

Next Generation Sequencing Market Share (%), By Region, 2024

Next Generation Sequencing Market - IMG1

Next Generation Sequencing (NGS) refers to the high-throughput DNA sequencing technologies that have substantially decreased the cost and increased the speed and throughput of DNA sequencing as compared to the first-generation Sanger sequencing. NGS allows researchers to sequence entire genomes, as well as to analyze the patterns of gene activity or expression on a large scale. Since its discovery in 2005, there have been tremendous improvements in NGS platforms which has enabled the sequencing of thousands to millions of DNA fragments in a single run. This massively parallel sequencing has revolutionized biological and biomedical research by allowing comprehensive characterization and discovery in genomic research. NGS finds applications across various fields including genetics, oncology, pharmacogenomics and personalized medicine.

Market Dynamics:

The global next generation sequencing market growth is driven by growing applications of genomics and precision medicine across various diseases. Rising prevalence of cancer and growing focus on pharmacogenomics is fueling the demand for NGS platforms in clinical diagnosis and monitoring. Growing genomics research activities, coupled with continuous decline in sequencing costs and introduction of portable and user-friendly sequencing instruments is also boosting the market growth. However, data management and analysis issues due to the massive amount of data generated from NGS, and limited bioinformatics knowledge remains a challenge. Meanwhile, developments in single-cell applications and cloud-based solutions for NGS data management presents lucrative growth opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global next generation sequencing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global next generation sequencing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Thermo Fisher Scientific Inc., Agilent Technologies Inc, bioMerieux SA, F. Hoffmann-La Roche Ltd, QIAGEN, Illumina Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, Bio-Rad Laboratories Inc., Pacific Biosciences, 10x Genomics, Promega Corporation, Macrogen Inc., Eurofins Scientific, DNASTAR Inc., and CD Genomics.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global next generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global next generation sequencing market.

Market Segmentation

Product Type:
- Instruments
- Reagents & Consumables
Sequencing Type:
- Whole Genome Sequencing
- Whole Exome Sequencing
- RNA Sequencing
- Targeted Re-sequencing
- Others
Application:
- Drug Discovery
- Personalized Medicine
- Genetic Screening
- Diagnostics
- Others
End User:
- Hospitals & Clinics
- Academic & Research Institutes
- Biopharmaceutical Companies
- Clinical Laboratories
- Others
Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc
- bioMerieux SA
- Hoffmann-La Roche Ltd
- QIAGEN
- Illumina Inc.
- Oxford Nanopore Technologies plc.
- BGI
- PerkinElmer Genomics
- Bio-Rad Laboratories Inc.
- Pacific Biosciences
- 10x Genomics
- Promega Corporation
- Macrogen Inc.
- Eurofins Scientific
- DNASTAR Inc.
- CD Genomics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Sequencing Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Next Generation Sequencing Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Next Generation Sequencing Market, By Product Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Reagents & Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

6. Global Next Generation Sequencing Market, By Sequencing Type, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Whole Genome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Whole Exome Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
RNA Sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Targeted Re-sequencing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

7. Global Next Generation Sequencing Market, By Application, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Personalized Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Genetic Screening
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

8. Global Next Generation Sequencing Market, By End User, 2019 - 2031, (US$ Billion)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Biopharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Clinical Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Billion)

9. Global Next Generation Sequencing Market, By Region, 2019 - 2031, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Sequencing Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Billion)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Agilent Technologies, Inc
bioMerieux SA
F. Hoffmann-La Roche Ltd
QIAGEN
Illumina, Inc.
Oxford Nanopore Technologies plc.
BGI
PerkinElmer Genomics
Bio-Rad Laboratories Inc.
Pacific Biosciences
10x Genomics
Promega Corporation
Macrogen Inc.
Eurofins Scientific
DNASTAR Inc.
CD Genomics